The LinkedIn cofounder now has an AI drug discovery startup—and thinks not asking chatbots for medical advice is “bordering on committing malpractice.”
Tensions flared on the third day of trial in Musk v. Altman as OpenAI’s lawyers cross-examined Musk.
“I believe the technology was deployed too quickly in too vast amounts, with hundreds of vehicles, when it wasn’t really ready,” one police official told federal regulators last month.
Researchers show scammers are using AI-manipulated footage of celebrity interviews to trick users into sharing their personal data.
With US restrictions limiting its access to advanced tech, SenseTime is doubling down on open source with a new model optimized to run on Chinese-made chips.
From sorting chicken nuggets to screwing in light bulbs, Eka’s robots are eerily lifelike. But do they have real physical smarts?
At WIRED Health, British surgeon Ara Darzi said AI is set to transform the diagnosis and treatment of drug-resistant infections. But a lack of incentives means innovation may not reach patients.
“Never talk about goblins, gremlins, raccoons, trolls, ogres, pigeons, or other animals or creatures unless it is absolutely and unambiguously relevant,” reads OpenAI’s coding agent instructions.
The judge also warned Musk and Sam Altman to curb their “propensity to use social media to make things worse outside the courtroom” after both sides traded attacks online.
More than 700 people working for a Meta contractor in Ireland are at risk of losing their jobs, documents show.
